Joint Preservation Therapy Solutions in Elk Grove, CA

What I’d check before adding joint preservation therapy here

Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 10.9% of adults in Elk Grove have diagnosed diabetes — 1.1 points below the U.S. 12% figure. 6.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick joint preservation therapy against that mix.

Cash PRP and Medicare CTPs in the same hallway

• Adult arthritis here is 21.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 6.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in California.
• JE articles change. A distributor that cannot point you at the current CTP LCD is selling units, not a program. That is the gap California practices actually hire us to close.
• Joe Bradley’s clinic uses the same portfolio we distribute. That is a process claim (we run the SOPs), not a fabricated Elk Grove outcome study. Local results still belong to the treating physician.

What CDC PLACES and JE each actually tell you

JE reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Elk Grove is 10.9% or not. PLACES is planning data. The LCD is the claim.

Before the first joint preservation therapy shipment